Cargando…

Flow Cytometry for the Analysis of α-Dystroglycan Glycosylation in Fibroblasts from Patients with Dystroglycanopathies

α-dystroglycan (α-DG) is a peripheral membrane protein that is an integral component of the dystrophin-glycoprotein complex. In an inherited subset of muscular dystrophies known as dystroglycanopathies, α-DG has reduced glycosylation which results in lower affinity binding to several extracellular m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stevens, Elizabeth, Torelli, Silvia, Feng, Lucy, Phadke, Rahul, Walter, Maggie C., Schneiderat, Peter, Eddaoudi, Ayad, Sewry, Caroline A., Muntoni, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3718821/ https://www.ncbi.nlm.nih.gov/pubmed/23894383 http://dx.doi.org/10.1371/journal.pone.0068958

Ejemplares similares

A new patient‐derived iPSC model for dystroglycanopathies validates a compound that increases glycosylation of α‐dystroglycan
por: Kim, Jihee, et al.
Publicado: (2019)

Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy
por: Kanagawa, Motoi, et al.
Publicado: (2009)

Global serum glycoform profiling for the investigation of dystroglycanopathies & Congenital Disorders of Glycosylation
por: Heywood, Wendy E., et al.
Publicado: (2016)

Zebrafish Fukutin family proteins link the unfolded protein response with dystroglycanopathies
por: Lin, Yung-Yao, et al.
Publicado: (2011)

Dystroglycan and dystroglycanopathies: Report of the 187th ENMC Workshop 11–13 November 2011, Naarden, The Netherlands
por: Brown, Susan C., et al.
Publicado: (2012)

Flow cytometry analysis: A quantitative method for collagen VI deficiency screening
por: Kim, J., et al.
Publicado: (2012)

biAb Mediated Restoration of the Linkage between Dystroglycan and Laminin-211 as a Therapeutic Approach for α-Dystroglycanopathies
por: Gumlaw, Nathan, et al.
Publicado: (2020)

A high–throughput digital script for multiplexed immunofluorescent analysis and quantification of sarcolemmal and sarcomeric proteins in muscular dystrophies
por: Scaglioni, Dominic, et al.
Publicado: (2020)

The Structure of the T190M Mutant of Murine α-Dystroglycan at High Resolution: Insight into the Molecular Basis of a Primary Dystroglycanopathy
por: Bozzi, Manuela, et al.
Publicado: (2015)

A novel high-throughput immunofluorescence analysis method for quantifying dystrophin intensity in entire transverse sections of Duchenne muscular dystrophy muscle biopsy samples
por: Sardone, Valentina, et al.
Publicado: (2018)

Functional Glycosylation of Dystroglycan Is Crucial for Thymocyte Development in the Mouse
por: Liou, Li-Ying, et al.
Publicado: (2010)

Transgenic Overexpression of LARGE Induces α-Dystroglycan Hyperglycosylation in Skeletal and Cardiac Muscle
por: Brockington, Martin, et al.
Publicado: (2010)

A translational approach to dystroglycanopathies: a frequent type of muscular dystrophy
por: Cirak, Sebahattin, et al.
Publicado: (2015)

Fukuyama-type congenital muscular dystrophy and defective glycosylation of α-dystroglycan
por: Saito, Fumiaki, et al.
Publicado: (2011)

Fer kinase regulates cell migration through α-dystroglycan glycosylation
por: Yoneyama, Tohru, et al.
Publicado: (2012)

A molecular overview of the primary dystroglycanopathies
por: Brancaccio, Andrea
Publicado: (2019)

Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of α-dystroglycan
por: Roscioli, Tony, et al.
Publicado: (2012)

LARGE Expression Augments the Glycosylation of Glycoproteins in Addition to α-Dystroglycan Conferring Laminin Binding
por: Zhang, Zhen, et al.
Publicado: (2011)

Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies
por: Belaya, Katsiaryna, et al.
Publicado: (2015)

POMK regulates dystroglycan function via LARGE1-mediated elongation of matriglycan
por: Walimbe, Ameya S, et al.
Publicado: (2020)

B4GAT1 is the priming enzyme for the LARGE-dependent functional glycosylation of α-dystroglycan
por: Praissman, Jeremy L, et al.
Publicado: (2014)

Identification and Modeling of a GT-A Fold in the α-Dystroglycan Glycosylating Enzyme LARGE1
por: Righino, Benedetta, et al.
Publicado: (2020)

ISPD Overexpression Enhances Ribitol-Induced Glycosylation of α-Dystroglycan in Dystrophic FKRP Mutant Mice
por: Cataldi, Marcela P., et al.
Publicado: (2019)

A mutation in mannose‐phosphate‐dolichol utilization defect 1 reveals clinical symptoms of congenital disorders of glycosylation type I and dystroglycanopathy
por: van Tol, Walinka, et al.
Publicado: (2019)

The glucuronyltransferase B4GAT1 is required for initiation of LARGE-mediated α-dystroglycan functional glycosylation
por: Willer, Tobias, et al.
Publicado: (2014)

Ribitol restores functionally glycosylated α-dystroglycan and improves muscle function in dystrophic FKRP-mutant mice
por: Cataldi, Marcela P., et al.
Publicado: (2018)

Distinct expression of functionally glycosylated alpha-dystroglycan in muscle and non-muscle tissues of FKRP mutant mice
por: Blaeser, Anthony, et al.
Publicado: (2018)

NAD+ enhances ribitol and ribose rescue of α-dystroglycan functional glycosylation in human FKRP-mutant myotubes
por: Ortiz-Cordero, Carolina, et al.
Publicado: (2021)

Prenatal muscle development in a mouse model for the secondary dystroglycanopathies
por: Kim, Jihee, et al.
Publicado: (2016)

Broad phenotypic spectrum and genotype-phenotype correlations in GMPPB-related dystroglycanopathies: an Italian cross-sectional study
por: Astrea, Guja, et al.
Publicado: (2018)

The administration of antisense oligonucleotide golodirsen reduces pathological regeneration in patients with Duchenne muscular dystrophy
por: Scaglioni, Dominic, et al.
Publicado: (2021)

LARGE expression in different types of muscular dystrophies other than dystroglycanopathy
por: Balci-Hayta, Burcu, et al.
Publicado: (2018)

Phenotype and Genotype Study of Chinese POMT2-Related α-Dystroglycanopathy
por: Chen, Xiao-Yu, et al.
Publicado: (2021)

Dystroglycanopathy: From Elucidation of Molecular and Pathological Mechanisms to Development of Treatment Methods
por: Kanagawa, Motoi
Publicado: (2021)

A dystroglycan ligand in the brain
por: Jegalian, Karin
Publicado: (2001)

Flow cytometry as an integrative method for the evaluation of vaccine immunogenicity: A validation approach
por: Gianchecchi, Elena, et al.
Publicado: (2023)

NAD+ improves neuromuscular development in a zebrafish model of FKRP-associated dystroglycanopathy
por: Bailey, Erin C., et al.
Publicado: (2019)

Clinical and electrophysiological evaluation of myasthenic features in an alpha-dystroglycanopathy cohort (FKRP- predominant)
por: Gonzalez-Perez, Paloma, et al.
Publicado: (2020)

Retinal Proteomics of a Mouse Model of Dystroglycanopathies Reveals Molecular Alterations in Photoreceptors
por: Uribe, Mary Luz, et al.
Publicado: (2021)

The conserved WW-domain binding sites in Dystroglycan C-terminus are essential but partially redundant for Dystroglycan function
por: Yatsenko, AS, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_6p3tq06diirfagqbh7apkfjv60